Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Review

  • Review
    Targeting the AKT protein kinase for cancer chemoprevention
    James A. Crowell, Vernon E. Steele and Judith R. Fay
    Mol Cancer Ther August 1 2007 6 (8) 2139-2148; DOI:10.1158/1535-7163.MCT-07-0120

Research Articles

  • Research Articles
    Bevacizumab plus 5-fluorouracil induce growth suppression in the CWR-22 and CWR-22R prostate cancer xenografts
    Huynh Hung
    Mol Cancer Ther August 1 2007 6 (8) 2149-2157; DOI:10.1158/1535-7163.MCT-07-0071

  • Research Articles
    A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo
    Qun-sheng Ji, Mark J. Mulvihill, Maryland Rosenfeld-Franklin, Andrew Cooke, Lixin Feng, Gilda Mak, Matthew O'Connor, Yan Yao, Caroline Pirritt, Elizabeth Buck, Alexandra Eyzaguirre, Lee D. Arnold, Neil W. Gibson and Jonathan A. Pachter
    Mol Cancer Ther August 1 2007 6 (8) 2158-2167; DOI:10.1158/1535-7163.MCT-07-0070

  • Research Articles
    Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity
    Fumiyuki Yamasaki, Dongwei Zhang, Chandra Bartholomeusz, Tamotsu Sudo, Gabriel N. Hortobagyi, Kaoru Kurisu and Naoto T. Ueno
    Mol Cancer Ther August 1 2007 6 (8) 2168-2177; DOI:10.1158/1535-7163.MCT-06-0514

  • Research Articles
    Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species–mediated damage
    Se-Yeong Oh, Young-Woo Sohn, Jong-Whi Park, Hyo-Jung Park, Hye-Min Jeon, Tae-Kyung Kim, Joong-Seob Lee, Ji-Eun Jung, Xun Jin, Yong Gu Chung, Young-Ki Choi, Seungkwon You, Jang-Bo Lee and Hyunggee Kim
    Mol Cancer Ther August 1 2007 6 (8) 2178-2187; DOI:10.1158/1535-7163.MCT-07-0111

  • Research Articles
    Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
    Jonathan D. Mosley, John T. Poirier, Darcie D. Seachrist, Melissa D. Landis and Ruth A. Keri
    Mol Cancer Ther August 1 2007 6 (8) 2188-2197; DOI:10.1158/1535-7163.MCT-07-0235

  • Research Articles
    Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts
    Neil R. Smith, Neil H. James, Ian Oakley, Anna Wainwright, Clive Copley, Jane Kendrew, Lynsey M. Womersley, Juliane M. Jürgensmeier, Stephen R. Wedge and Simon T. Barry
    Mol Cancer Ther August 1 2007 6 (8) 2198-2208; DOI:10.1158/1535-7163.MCT-07-0142

  • Research Articles
    AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
    Barry R. Davies, Armelle Logie, Jennifer S. McKay, Paul Martin, Samantha Steele, Richard Jenkins, Mark Cockerill, Sue Cartlidge and Paul D. Smith
    Mol Cancer Ther August 1 2007 6 (8) 2209-2219; DOI:10.1158/1535-7163.MCT-07-0231

  • Research Articles
    Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth
    Honglin Hao, Vanessa M. Muniz-Medina, Heena Mehta, Nancy E. Thomas, Vladimir Khazak, Channing J. Der and Janiel M. Shields
    Mol Cancer Ther August 1 2007 6 (8) 2220-2229; DOI:10.1158/1535-7163.MCT-06-0728

  • Research Articles
    Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo
    Ghenet K. Hagos, Robert E. Carroll, Tatiana Kouznetsova, Qian Li, Violeta Toader, Patricia A. Fernandez, Steven M. Swanson and Gregory R.J. Thatcher
    Mol Cancer Ther August 1 2007 6 (8) 2230-2239; DOI:10.1158/1535-7163.MCT-07-0069

  • Research Articles
    Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein
    Angela Ping Ping Ng, Dawn Sijin Nin, Jek Howe Fong, Divya Venkataraman, Chien-Shing Chen and Matiullah Khan
    Mol Cancer Ther August 1 2007 6 (8) 2240-2248; DOI:10.1158/1535-7163.MCT-06-0705

  • Research Articles
    CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling
    Chris R. Evelyn, Susan M. Wade, Qin Wang, Mei Wu, Jorge A. Iñiguez-Lluhí, Sofia D. Merajver and Richard R. Neubig
    Mol Cancer Ther August 1 2007 6 (8) 2249-2260; DOI:10.1158/1535-7163.MCT-06-0782

  • Research Articles
    Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data
    David G. Covell, Ruili Huang and Anders Wallqvist
    Mol Cancer Ther August 1 2007 6 (8) 2261-2270; DOI:10.1158/1535-7163.MCT-06-0787

  • Research Articles
    Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15
    Joseph Tung-Chieh Chang, Shih-Hsuan Chan, Chien-Yu Lin, Ting-Yang Lin, Hung-Ming Wang, Chun-Ta Liao, Tzu-Hao Wang, Li-Yu Lee and Ann-Joy Cheng
    Mol Cancer Ther August 1 2007 6 (8) 2271-2279; DOI:10.1158/1535-7163.MCT-06-0801

  • Research Articles
    Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice
    Urban Emmenegger, Yuval Shaked, Shan Man, Guido Bocci, Ivan Spasojevic, Giulio Francia, Andrew Kouri, Robert Coke, William Cruz-Munoz, Susan M. Ludeman, O. Michael Colvin and Robert S. Kerbel
    Mol Cancer Ther August 1 2007 6 (8) 2280-2289; DOI:10.1158/1535-7163.MCT-07-0181

  • Research Articles
    The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity
    Sheila Miknyoczki, Hong Chang, Jennifer Grobelny, Sonya Pritchard, Candace Worrell, Natalie McGann, Mark Ator, Jean Husten, James Deibold, Robert Hudkins, Allison Zulli, Ralph Parchment and Bruce Ruggeri
    Mol Cancer Ther August 1 2007 6 (8) 2290-2302; DOI:10.1158/1535-7163.MCT-07-0062

  • Research Articles
    The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non–small cell lung carcinoma cells to DNA double-strand break–induced cell death
    Anya G. Polischouk, Åsa Holgersson, Dali Zong, Bo Stenerlöw, Hanna L. Karlsson, Lennart Möller, Kristina Viktorsson and Rolf Lewensohn
    Mol Cancer Ther August 1 2007 6 (8) 2303-2309; DOI:10.1158/1535-7163.MCT-06-0402

  • Research Articles
    Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells
    Shinji Oie, Mayumi Ono, Hiroto Fukushima, Fumihito Hosoi, Hirohisa Yano, Yuichiro Maruyama, Masamichi Kojiro, Tadafumi Terada, Kazuyuki Hirano, Michihiko Kuwano and Yuji Yamada
    Mol Cancer Ther August 1 2007 6 (8) 2310-2318; DOI:10.1158/1535-7163.MCT-06-0281

  • Research Articles
    A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-κB, COX-1, and COX-2
    Ann S.J. Yeoh, Rachel J. Gibson, Eric E.K. Yeoh, Joanne M. Bowen, Andrea M. Stringer, Kar A. Giam and Dorothy M.K. Keefe
    Mol Cancer Ther August 1 2007 6 (8) 2319-2327; DOI:10.1158/1535-7163.MCT-07-0113

  • Research Articles
    A bifunctional colchicinoid that binds to the androgen receptor
    Nima Sharifi, Ernest Hamel, Markus A. Lill, Prabhakar Risbood, Charles T. Kane Jr., Md Tafazzal Hossain, Amanda Jones, James T. Dalton and William L. Farrar
    Mol Cancer Ther August 1 2007 6 (8) 2328-2336; DOI:10.1158/1535-7163.MCT-07-0163

  • Research Articles
    A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells
    Arnold H. van der Luit, Stefan R. Vink, Jeffrey B. Klarenbeek, Daniel Perrissoud, Eric Solary, Marcel Verheij and Wim J. van Blitterswijk
    Mol Cancer Ther August 1 2007 6 (8) 2337-2345; DOI:10.1158/1535-7163.MCT-07-0202

  • Research Articles
    213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe
    Christof Seidl, Matthias Port, Klaus-Peter Gilbertz, Alfred Morgenstern, Frank Bruchertseifer, Markus Schwaiger, Barbara Röper, Reingard Senekowitsch-Schmidtke and Michael Abend
    Mol Cancer Ther August 1 2007 6 (8) 2346-2359; DOI:10.1158/1535-7163.MCT-07-0132

  • Research Articles
    Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma–associated herpesvirus
    Tamara K. Nun, David J. Kroll, Nicholas H. Oberlies, Djaja D. Soejarto, Ryan J. Case, Pius Piskaut, Teatulohi Matainaho, Chelsey Hilscher, Ling Wang, Dirk P. Dittmer, Shou-Jian Gao and Blossom Damania
    Mol Cancer Ther August 1 2007 6 (8) 2360-2370; DOI:10.1158/1535-7163.MCT-07-0108

  • Research Articles
    Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth
    Maayan Duvshani-Eshet, Ofra Benny, Avigail Morgenstern and Marcelle Machluf
    Mol Cancer Ther August 1 2007 6 (8) 2371-2382; DOI:10.1158/1535-7163.MCT-07-0019

Correction

  • Correction
    Article on TNF-α—based accentuation in cryoinjury
    Mol Cancer Ther August 1 2007 6 (8) 2383-2383; DOI:10.1158/1535-7163.MCT-6-8-COR

Back to top
PreviousNext
Molecular Cancer Therapeutics: 6 (8)
August 2007
Volume 6, Issue 8
  • Table of Contents
  • About the Cover

Sign up for alerts

Jump to

  • Review
  • Research Articles
  • Correction
Advertisement
  • Most Cited
  • Most Read
Loading
  • Anti-KIT DNA Aptamer Labeling in GIST
  • SLFN11 Expression in Prostate Cancer
  • Single-cell RNA-seq to Uncover Metastatic Targets in PDAC
  • Tipifarnib as a Precision Therapy for HRAS-Mutant HNSCC
  • ARX788 Efficacy in HER2-low and T-DM1–resistant Cancers
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement